Q3 FY2026 · ended Sep 30, 2026 · Revenue $656.96M, +13.2% YoY · Filed Nov 5, 2026
Privia Health Group, Inc. (PRVA) files with the SEC under industry code 8000, Services-Health Services. In Q3 of fiscal 2026, the quarter ended Sep 30, 2026, it reported revenue of $657.0 million and net income of $13.5 million. As of Sep 30, 2026 it held $446.3 million in cash and investments and $8.3 million in total debt.
Revenue
$656.96M
+13.2% vs year-ago quarter
Net income
$13.49M
+96.6% vs year-ago quarter
Operating cash flow
$28.94M
-44.3% vs year-ago quarter
Free cash flow
—
EPS
$0.10
+100.0% vs year-ago quarter
Dividend per share
None
Shares outstanding
127.77M
+3.9% vs year-ago quarter
Net cash
$438.03M
Q3 FY2026
Operating margin
2.1%
TTM
Company profile
- Industry
- Services-Health Services (SIC 8000)
- Listed as
- PRVA (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Arlington, VA
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1759655
- Former names
- PH Group Parent Corp. (until Mar 11, 2020)
Other Services-Health Services companies
- LifeStance Health Group, Inc. LFST
- GeneDx Holdings Corp. WGS
- Pennant Group, Inc. PNTG
- U S Physical Therapy Inc /NV USPH
- InnovAge Holding Corp. INNV
- Omada Health, Inc. OMDA
- P3 Health Partners Inc. PIII
- Alps Group Inc ALPS
Key figures
Fiscal-year totals from the annual reports; switch to Annual for the full-year view. Balance sheet lines are as of each year end.
| Line | Q3 FY2026 Sep 30, 2026 |
Q2 FY2026 Jun 30, 2026 |
Q1 FY2026 Mar 31, 2026 |
Q4 FY2025 Dec 31, 2025 |
Q3 FY2025 Sep 30, 2025 |
|---|---|---|---|---|---|
| Revenue | $657.0M | $632.6M | $603.8M | $541.2M | $580.4M |
| Operating income | $20.5M | $11.8M | $7.4M | $11.3M | $14.4M |
| Net income | $13.5M | $9.0M | $3.1M | $9.2M | $6.9M |
| Diluted EPS | $0.10 | $0.07 | $0.02 | $0.07 | $0.05 |
| Operating cash flow | $28.9M | $1.1M | -$49.5M | $127.5M | $52.0M |
| Total assets | $1.6B | $1.5B | $1.4B | $1.4B | $1.4B |
| Total liabilities | $690.8M | $650.5M | $612.0M | $578.4M | $588.2M |
| Stockholders' equity | $815.7M | $782.3M | $753.1M | $737.2M | $709.1M |
| Cash and investments | $446.3M | $412.2M | $419.5M | $479.7M | $441.4M |
| Total debt | $8.3M | $8.7M | $9.0M | $9.5M | $6.2M |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-Q | Quarterly report | Nov 5, 2026 | Sep 30, 2026 |
| 8-K |
Current report
Results of operations
|
Nov 5, 2026 | Nov 5, 2026 |
| 8-K |
Current report
Officer or director change
|
Aug 18, 2026 | Aug 12, 2026 |
| 10-Q | Quarterly report | Aug 6, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 6, 2026 | Aug 6, 2026 |
| 8-K |
Current report
Officer or director change
|
Jul 7, 2026 | Jul 6, 2026 |
All 603 Privia Health Group, Inc. SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.